General Information of the Compound
Compound ID
CP0057115
Compound Name
4-(4-Chlorobenzyl)-1-(1H-pyrazolo[3,4-b]pyridin-4-yl)-piperidin-4-ylamine
    Show/Hide
Structure
Formula
C18H20ClN5
Molecular Weight
341.846
Canonical SMILES
NC1(Cc2ccc(Cl)cc2)CCN(CC1)c1ccnc2[nH]ncc12
    Show/Hide
InChI
InChI=1S/C18H20ClN5/c19-14-3-1-13(2-4-14)11-18(20)6-9-24(10-7-18)16-5-8-21-17-15(16)12-22-23-17/h1-5,8,12H,6-7,9-11,20H2,(H,21,22,23)
    Show/Hide
InChIKey
ZFVMFXQNRBEZFM-UHFFFAOYSA-N
Physicochemical Property
logP
3.1517
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
70.83
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 45142258
SID: 92392250
ChEMBL ID
CHEMBL598013
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00845, RAC-alpha serine/threonine-protein kinase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000102 U-87MG ATCC Homo sapiens (Human)  1
1
GI50 = 2.7 nM
   TI
   LI
   LO
   TS